Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00681655 · ClinicalTrials.gov registry record · NA
GABRA2 and the Pharmacokinetics of Risk for Alcoholism (GPRA)
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
NCT00681655 is a NA study that has completed, run by Indiana University. The registered enrollment target is 141 participants.
The verdict
NCT00681655, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
Study Summary
This study will assess whether the presence of a particular form of a gene, GABRA2, affects the functional responses of the human brain to alcohol administration and will evaluate that relationship in the context of factors known to increase the risk for future alcoholism.
Interventions
- OTHER Placebo
- OTHER Alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-04-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00681655
The ClinicalTrials.gov registry entry for NCT00681655 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00681655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00681655 about?
NCT00681655 is a clinical study titled "GABRA2 and the Pharmacokinetics of Risk for Alcoholism (GPRA)". This study will assess whether the presence of a particular form of a gene, GABRA2, affects the functional responses of the human brain to alcohol administration and will evaluate that relationship in the context of factors known to increase the risk for future alcoholism.
What is the current status of trial NCT00681655?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2008-05. Estimated completion is 2012-04-14.
What interventions are being tested in trial NCT00681655?
The interventions under investigation include: Placebo (OTHER), Alcohol (OTHER).
Who is sponsoring clinical trial NCT00681655?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.